BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37894424)

  • 1. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
    Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial.
    Park EJ; Baek JH; Choi GS; Park WC; Yu CS; Kang SB; Min BS; Kim JH; Kim HR; Lee BH; Oh JH; Jeong SY; Jung M; Ahn JB; Baik SH
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
    J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.
    Kanemitsu Y; Shitara K; Mizusawa J; Hamaguchi T; Shida D; Komori K; Ikeda S; Ojima H; Ike H; Shiomi A; Watanabe J; Takii Y; Yamaguchi T; Katsumata K; Ito M; Okuda J; Hyakudomi R; Shimada Y; Katayama H; Fukuda H;
    J Clin Oncol; 2021 Apr; 39(10):1098-1107. PubMed ID: 33560877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
    Lin Q; Ding K; Zhao R; Wang H; Wei Y; Ren L; Ye Q; Cui Y; He G; Tang W; Feng Q; Zhu D; Chang W; Wang X; Liang L; Zhou G; Liang F; Ye F; Wang J; Fan J; Xu J
    Eur J Cancer; 2023 Sep; 191():112961. PubMed ID: 37473466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort Analysis.
    Huang L; Wei G; Chen N; Liu J; Wang Z; Yu Y; Qiu M
    Clin Med Insights Oncol; 2022; 16():11795549221085054. PubMed ID: 35355515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
    Fanotto V; Rossini D; Casagrande M; Bergamo F; Spagnoletti A; Santini D; Antoniotti C; Cupini S; Daniel F; Nasca V; Vetere G; Zaniboni A; Borelli B; Carullo M; Conca V; Passardi A; Tamburini E; Masi G; Pella N; Cremolini C
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis.
    Liang Z; Liu Z; Huang C; Chen X; Zhang Z; Xiang M; Hu W; Wang J; Feng X; Yao X
    Front Surg; 2022; 9():1047373. PubMed ID: 36684350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
    Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
    Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
    Rahbari NN; Biondo S; Frago R; Feißt M; Kreisler E; Rossion I; Serrano M; Jäger D; Lehmann M; Sommer F; Dignass A; Bolling C; Vogel I; Bork U; Büchler MW; Folprecht G; Kieser M; Lordick F; Weitz J;
    J Clin Oncol; 2024 May; 42(13):1531-1541. PubMed ID: 38412408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
    de Mestier L; Neuzillet C; Pozet A; Desot E; Deguelte-Lardière S; Volet J; Karoui M; Kianmanesh R; Bonnetain F; Bouché O
    Eur J Surg Oncol; 2014 Jun; 40(6):685-91. PubMed ID: 24630774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
    Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
    Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of primary tumor location and resection on survival in metastatic colorectal cancer.
    Tharin Z; Blanc J; Alaoui IC; Bertaut A; Ghiringhelli F
    World J Gastrointest Oncol; 2020 Nov; 12(11):1296-1310. PubMed ID: 33250962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases.
    Doah KY; Shin US; Jeon BH; Cho SS; Moon SM
    Ann Coloproctol; 2021 Apr; 37(2):94-100. PubMed ID: 33979907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
    Urvay S; Eren T; Civelek B; Kilickap S; Yetiysigit T; Ozaslan E
    J BUON; 2020; 25(2):939-944. PubMed ID: 32521889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial.
    Kim CW; Baek JH; Choi GS; Yu CS; Kang SB; Park WC; Lee BH; Kim HR; Oh JH; Kim JH; Jeong SY; Ahn JB; Baik SH
    Trials; 2016 Jan; 17():34. PubMed ID: 26782254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.